Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04487236 |
|
Recruitment Status :
Recruiting
First Posted : July 27, 2020
Last Update Posted : October 12, 2022
|
Sponsor:
Suzhou Zanrong Pharma Limited
Information provided by (Responsible Party):
Suzhou Zanrong Pharma Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 30, 2022 |
| Estimated Study Completion Date : | June 30, 2024 |